JP2021533789A5 - - Google Patents
Info
- Publication number
- JP2021533789A5 JP2021533789A5 JP2021507972A JP2021507972A JP2021533789A5 JP 2021533789 A5 JP2021533789 A5 JP 2021533789A5 JP 2021507972 A JP2021507972 A JP 2021507972A JP 2021507972 A JP2021507972 A JP 2021507972A JP 2021533789 A5 JP2021533789 A5 JP 2021533789A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- virus
- disease
- oncolytic
- virus according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862718990P | 2018-08-16 | 2018-08-16 | |
| US62/718,990 | 2018-08-16 | ||
| US201862741404P | 2018-10-04 | 2018-10-04 | |
| US62/741,404 | 2018-10-04 | ||
| US201862754622P | 2018-11-02 | 2018-11-02 | |
| US62/754,622 | 2018-11-02 | ||
| US201962813375P | 2019-03-04 | 2019-03-04 | |
| US62/813,375 | 2019-03-04 | ||
| PCT/US2019/046823 WO2020037206A1 (en) | 2018-08-16 | 2019-08-16 | Recombinant myxoma viruses and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021533789A JP2021533789A (ja) | 2021-12-09 |
| JP2021533789A5 true JP2021533789A5 (https=) | 2022-08-22 |
Family
ID=69525939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507972A Pending JP2021533789A (ja) | 2018-08-16 | 2019-08-16 | 組換え粘液腫ウイルスおよびその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210196771A1 (https=) |
| EP (1) | EP3837354A4 (https=) |
| JP (1) | JP2021533789A (https=) |
| KR (1) | KR20210094509A (https=) |
| CN (1) | CN112771157A (https=) |
| AU (1) | AU2019321667A1 (https=) |
| BR (1) | BR112021002639A2 (https=) |
| CA (1) | CA3109216A1 (https=) |
| IL (1) | IL280854A (https=) |
| MX (1) | MX2021001883A (https=) |
| WO (1) | WO2020037206A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210031485A (ko) | 2018-07-13 | 2021-03-19 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | Tnf를 발현하는 점액종 바이러스로 암을 치료하는 방법 |
| US11591616B1 (en) | 2019-04-22 | 2023-02-28 | Colorado State University Research Foundation | Apoptotic upregulation by myxoma virus expressing walleye dermal sarcoma virus orfC |
| BR112022000928A2 (pt) | 2019-07-19 | 2022-03-08 | Seneca Therapeutics Inc | Terapia oncolítica do vírus seneca valley de segunda geração: composições e métodos da mesma |
| TW202122411A (zh) | 2019-09-02 | 2021-06-16 | 美國亞利桑那州立大學亞利桑那州評議委員會 | 以黏液瘤(myxoma)病毒治療癌症之新穎溶瘤病毒平臺 |
| EP4041266A1 (en) * | 2019-10-10 | 2022-08-17 | Arizona Board of Regents on behalf of Arizona State University | Oncolytic virus comprising immunomodulatory transgenes and uses thereof |
| CA3168771A1 (en) * | 2020-02-20 | 2021-08-26 | Eric Bartee | Recombinant myxoma viruses and uses thereof |
| US12071633B2 (en) | 2020-10-13 | 2024-08-27 | Kriya Therapeutics, Inc. | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer |
| WO2022139440A1 (ko) * | 2020-12-22 | 2022-06-30 | 바이로큐어 주식회사 | 신규한 재조합 믹소마바이러스 및 이의 용도 |
| EP4281549A4 (en) * | 2021-01-19 | 2025-05-07 | Seneca Therapeutics, Inc. | ONCOLYTIC THERAPY COMPOSITIONS CONTAINING SENECA VALLEY VIRUS AND METHODS THEREFOR |
| JP2024508920A (ja) * | 2021-03-01 | 2024-02-28 | オンコミクス セラピューティクス，インク． | 多武装の粘液腫ウイルス |
| EP4490271A1 (en) * | 2022-03-10 | 2025-01-15 | City of Hope | Membrane-bound il-12 for cellular immunotherapy |
| JPWO2024111633A1 (https=) * | 2022-11-24 | 2024-05-30 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2670804A1 (en) * | 2006-05-19 | 2007-11-29 | Sanofi Pasteur Inc. | Immunological composition |
| WO2008070367A2 (en) * | 2006-11-01 | 2008-06-12 | Facet Biotech Corporation | Mammalian cell-based immunoglobulin display libraries |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| RU2696312C2 (ru) * | 2014-07-16 | 2019-08-01 | Трансген Са | Онколитический вирус для экспрессии модуляторов иммунологических контрольных точек |
| ES2924402T3 (es) * | 2015-10-02 | 2022-10-06 | Symphogen As | Anticuerpos anti-PD-1 y composiciones |
| HUE048265T2 (hu) * | 2015-10-27 | 2020-08-28 | Pharmassist Ltd | Eljárás PD-L1 mennyiségi meghatározására |
| WO2018049248A1 (en) * | 2016-09-09 | 2018-03-15 | Icellhealth Consulting Llc | Oncolytic virus equipped with bispecific engager molecules |
-
2019
- 2019-08-16 MX MX2021001883A patent/MX2021001883A/es unknown
- 2019-08-16 WO PCT/US2019/046823 patent/WO2020037206A1/en not_active Ceased
- 2019-08-16 EP EP19849867.7A patent/EP3837354A4/en not_active Withdrawn
- 2019-08-16 BR BR112021002639-8A patent/BR112021002639A2/pt not_active Application Discontinuation
- 2019-08-16 CN CN201980060542.9A patent/CN112771157A/zh active Pending
- 2019-08-16 US US17/268,656 patent/US20210196771A1/en not_active Abandoned
- 2019-08-16 KR KR1020217006855A patent/KR20210094509A/ko not_active Ceased
- 2019-08-16 CA CA3109216A patent/CA3109216A1/en active Pending
- 2019-08-16 JP JP2021507972A patent/JP2021533789A/ja active Pending
- 2019-08-16 AU AU2019321667A patent/AU2019321667A1/en not_active Abandoned
-
2021
- 2021-02-14 IL IL280854A patent/IL280854A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533789A5 (https=) | ||
| O'Bryan et al. | Oncolytic virotherapy for breast cancer treatment | |
| Shi et al. | Combining oncolytic viruses with cancer immunotherapy: establishing a new generation of cancer treatment | |
| Chen et al. | Oncolytic virotherapy in cancer treatment: challenges and optimization prospects | |
| WO2020037206A4 (en) | Recombinant myxoma viruses and uses thereof | |
| JP6794442B2 (ja) | 新規な遺伝子組換えワクシニアウイルス | |
| US20220056480A1 (en) | Modified orthopoxvirus vectors | |
| US20240229069A9 (en) | Modified orthopoxvirus vectors | |
| O’Leary et al. | Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose | |
| BR112019013215A2 (pt) | vírus oncolítico, composição farmacêutica, produto de fabricação, método para tratar câncer e uso | |
| Li et al. | Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review | |
| JP7754891B2 (ja) | Ｃｃｌ２１をコードする組換えラブドウイルス | |
| JP2021527694A5 (https=) | ||
| Chaurasiya et al. | Viroimmunotherapy for breast cancer: Promises, problems and future directions | |
| JP2018510158A (ja) | 抗体組み合わせを用いるウイルス療法 | |
| JP2022536929A5 (https=) | ||
| BR112021001117A2 (pt) | células cancerígenas modificadas, composição farmacêutica, linha celular, métodos para fazer células cancerígenas modificadas e para estimular uma resposta imune, vetor de expressão isolado ou combinação de vetores de expressão isolados, e, uma ou mais células cancerígenas modificadas | |
| WO2020067085A1 (ja) | 腫瘍溶解性ワクシニアウイルスと免疫チェックポイント阻害剤との併用によるがん療法並びにこれに用いるための医薬組成物及び組合せ医薬 | |
| CN110564767A (zh) | 一种减毒病毒载体系统及其在制备抗恶性肿瘤的药物中的应用及药物使用方法 | |
| TWI817159B (zh) | 重組牛痘病毒 | |
| Ekeke et al. | Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies: CN Ekeke et al. | |
| JP2023552289A5 (https=) | ||
| Akunne et al. | Emerging strategies in cancer immunotherapy: Expanding horizons and future perspectives | |
| Liu et al. | Oncolytic vaccinia virotherapy for endometrial cancer | |
| JP7618308B2 (ja) | 製薬におけるフェノチアジン類又は類似の構造を持つ化合物の新しい使用 |